• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于革兰氏阴性杆菌脑膜炎的胃肠外注射用甲氧苄啶/磺胺甲恶唑

Parenteral trimethoprim/sulfamethoxazole for gram-negative bacillary meningitis.

作者信息

McConville J H, Manzella J P

出版信息

Am J Med Sci. 1984 Mar-Apr;287(2):43-5. doi: 10.1097/00000441-198403000-00011.

DOI:10.1097/00000441-198403000-00011
PMID:6369985
Abstract

Three adults with gram-negative bacillary meningitis were treated with an intravenous preparation of trimethoprim and sulfamethoxazole. This therapy sterilized the cerebrospinal fluid in each case. The infections occurred as complications of neurosurgery, trauma and chronic otitis media. Serratia marcescens was the causative organism in two patients and Proteus vulgaris in the third. The infecting organism was eradicated within three to 17 days of beginning intravenous trimethoprim/sulfamethoxazole. Followup CSF cultures after completing therapy were sterile. These cases suggest intravenous trimethoprim/sulfamethoxazole may be effective treatment for some cases of gram negative bacillary meningitis.

摘要

三名患有革兰氏阴性杆菌性脑膜炎的成年人接受了静脉注射甲氧苄啶和磺胺甲恶唑制剂的治疗。该疗法使每例患者的脑脊液除菌。这些感染是神经外科手术、创伤和慢性中耳炎的并发症。两名患者的致病菌为粘质沙雷氏菌,第三名患者的致病菌为普通变形杆菌。在开始静脉注射甲氧苄啶/磺胺甲恶唑后的3至17天内,感染病菌被根除。完成治疗后的脑脊液培养结果均无菌。这些病例表明,静脉注射甲氧苄啶/磺胺甲恶唑可能是治疗某些革兰氏阴性杆菌性脑膜炎病例的有效方法。

相似文献

1
Parenteral trimethoprim/sulfamethoxazole for gram-negative bacillary meningitis.用于革兰氏阴性杆菌脑膜炎的胃肠外注射用甲氧苄啶/磺胺甲恶唑
Am J Med Sci. 1984 Mar-Apr;287(2):43-5. doi: 10.1097/00000441-198403000-00011.
2
Gram-negative bacillary meningitis.革兰氏阴性杆菌性脑膜炎
JAMA. 1982 Sep 10;248(10):1217-8.
3
Intravenous sulfamethoxazole and trimethoprim for serious gram-negative bacillary infection.
Arch Intern Med. 1983 Sep;143(9):1709-12.
4
Trimethoprim-sulfamethoxazole for bacterial meningitis.用于细菌性脑膜炎的复方新诺明
Ann Intern Med. 1984 Jun;100(6):881-90. doi: 10.7326/0003-4819-100-6-881.
5
Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
Rev Infect Dis. 1987 Mar-Apr;9 Suppl 2:S168-76. doi: 10.1093/clinids/9.supplement_2.s168.
6
Intravenous sulfamethoxazole-trimethoprim: pharmacokinetics, therapeutic indications, and adverse reactions.
Pharmacotherapy. 1981 Nov-Dec;1(3):206-11. doi: 10.1002/j.1875-9114.1981.tb02542.x.
7
Clinical evaluation of intravenous trimethoprim-sulfamethoxazole for serious infections.
Rev Infect Dis. 1982 Mar-Apr;4(2):332-7. doi: 10.1093/clinids/4.2.332.
8
[Endocarditis caused by Serratia marcescens sterilized by cefotaxime and trimethoprim-sulfamethoxazole].
Rev Esp Cardiol. 1982;35(1):79-81.
9
Trimethoprim-sulfamethoxazole.甲氧苄啶-磺胺甲恶唑
Mayo Clin Proc. 1983 Mar;58(3):147-53.
10
Prostatitis. Observations on activity of trimethoprim-sulfamethoxazole in the prostate.前列腺炎。关于甲氧苄啶-磺胺甲恶唑在前列腺中活性的观察。
J Infect Dis. 1973 Nov;128:Suppl:679-85 p. doi: 10.1093/infdis/128.supplement_3.s679.

引用本文的文献

1
Chemotherapy for bacterial infections of the central nervous system.中枢神经系统细菌感染的化疗。
West J Med. 1987 Sep;147(3):309-13.
2
Serratia marcescens meningitis.粘质沙雷氏菌脑膜炎
J Clin Microbiol. 1991 Apr;29(4):822-3. doi: 10.1128/jcm.29.4.822-823.1991.